| Phase 3 |
| NCT06617715 |
Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine |
Pneumococcal Infectious Disease |
Recruiting |
2026-01-28 |
| NCT07832500 |
A Lot-to-Lot Consistency Clinical Trial of PCV13 |
Pneumococcal Infectious Diseases |
Not Yet Recruiting |
2026-09-22 |
| NCT07633119 |
A Phase Ⅲ Clinical Study of SNA02-48 Injection |
Tetanus |
Not Yet Recruiting |
2026-06-08 |
| NCT07593924 |
Clinical Trial of PCV13 in Infants Aged Approximately 2 Months (42 to 89 Days) |
Pneumococcal Infectious Diseases |
Not Yet Recruiting |
2026-05-18 |
| Phase 2 |
| NCT07300644 |
Clinical Trial of PCV24 in Infants and Children Aged 2 Months to 5 Years |
Pneumococcal Infectious Disease |
Recruiting |
2025-12-24 |
| NCT06967272 |
PhaseⅡClinical Trial of Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine… |
Rotavirus Gastroenteritis |
Recruiting |
2025-08-22 |
| Phase 1 |
| NCT06800261 |
Clinical Trial of PCV24 in Infants Aged 2-23 Months |
Pneumococcal Infectious Disease |
Recruiting |
2026-01-28 |
| NCT07374510 |
Phase Ia Clinical Trial of Group ACYW135X Meningococcal Conjugate Vaccine |
Meningococcal Meningitis |
Not Yet Recruiting |
2026-01-28 |